ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

GNS Genus Plc

1,868.00
84.00 (4.71%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Genus Plc LSE:GNS London Ordinary Share GB0002074580 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  84.00 4.71% 1,868.00 1,854.00 1,860.00 1,872.00 1,776.00 1,776.00 80,575 16:35:03
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Coml Physical, Biologcl Resh 689.7M 33.3M 0.5043 36.84 1.23B

Genus PLC Director/PDMR Shareholding (7856R)

04/03/2019 3:11pm

UK Regulatory


Genus (LSE:GNS)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Genus Charts.

TIDMGNS

RNS Number : 7856R

Genus PLC

04 March 2019

4 March 2019

Genus plc

Director/PDMR Shareholding

Genus plc (LSE: GNS) announces that, further to the vesting of contingent rights over ordinary shares in Genus on 5 January 2019 under an individual restricted stock award agreement, Dr. Nate Zwald, a member of the Genus Executive Leadership Team, sold ordinary shares in Genus on 1 March 2019, on the London Stock Exchange to offset income tax and social security liabilities due on the exercise, and retained the balance of ordinary shares.

The below notification made in accordance with the requirements of the EU Market Abuse Regulation, gives further detail of the number of contingent rights exercised and ordinary shares sold.

For further information please contact:

Genus:

Vaughn Walton, Interim Deputy Company Secretary Tel: +44 (0)1256 347100

Table A - GELT Restricted Stock Award Exercise

 
 1.                Details of the person discharging managerial responsibilities 
                    / person closely associated 
       a.          Name                            Dr. Nate Zwald 
                  ==============================  ====================================================== 
       2.          Reason for the notification 
                  ====================================================================================== 
       a.          Position/status                 Chief Operating Officer, Genus ABS Dairy 
                  ==============================  ====================================================== 
       b.          Initial notification            Initial notification 
                    /Amendment 
                  ==============================  ====================================================== 
       3.          Details of the issuer, emission allowance market participant, 
                    auction platform, auctioneer or auction monitor 
                  ====================================================================================== 
       a.          Name                            Genus plc 
                  ==============================  ====================================================== 
       b.          LEI                             54930022EOITNKSIGH56 
                  ==============================  ====================================================== 
       4.          Details of the transaction(s): section to be repeated for (i) 
                    each type of instrument; (ii) each type of transaction; (iii) 
                    each date; and (iv) each place where transactions have been 
                    conducted 
                  ====================================================================================== 
       a.          Description of                  Ordinary shares of 10p each 
                    the 
                    Financial instrument, 
                    type of instrument              GB0002074580 
                    Identification 
                    code 
                  ==============================  ====================================================== 
       b.          Nature of the                   Acquisition of shares following exercise of 
                    transaction                     3,612 contingent rights under an individual 
                                                    restricted stock award agreement. 
                  ==============================  ====================================================== 
       c.          Price(s) and volume(s)            Price(s)   Volume(s) 
                                                      0p         3,612 
                                                                ---------- 
                  ==============================  ====================================================== 
       d.               Aggregated information       Average price(s)   Total volume(s) 
                          *    Aggregated volume      0p                 3,612 
                                                                        ---------------- 
 
                          *    Price 
                  ==============================  ====================================================== 
       e.          Date of the transaction         2019-03-01 
                  ==============================  ====================================================== 
       f.          Place of the transaction        Outside a trading venue. 
                  ==============================  ====================================================== 
                   Details of the transaction(s): section to be repeated for (i) 
              4.    each type of instrument; (ii) each type of transaction; (iii) 
                    each date; and (iv) each place where transactions have been 
                    conducted 
                  ====================================================================================== 
             a.    Description of                  Ordinary shares of 10p each 
             a.     the 
                    Financial instrument, 
                    type of instrument              GB0002074580 
                    Identification 
                    code 
                  ==============================  ====================================================== 
             b.    Nature of the                   Sale of 1,293 shares arising from the exercise 
             b.     transaction                     of contingent rights under an individual restricted 
                                                    stock award agreement, to offset income tax 
                                                    and social security liabilities due on the exercise. 
                  ==============================  ====================================================== 
             c.    Price(s) and volume(s)            Price(s)      Volume(s) 
             c.                                       2,198.0404p   1,293 
                                                                   ---------- 
                  ==============================  ====================================================== 
             d.         Aggregated information       Average price(s)   Total volume(s) 
             d.           *    Aggregated volume      2,198.0404p        1,293 
                                                                        ---------------- 
 
                          *    Price 
                  ==============================  ====================================================== 
       e.          Date of the transaction         2019-03-01 
                  ==============================  ====================================================== 
       f.          Place of the transaction        London Stock Exchange, Main Market (XLON) 
                  ==============================  ====================================================== 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHUSAVRKRAORAR

(END) Dow Jones Newswires

March 04, 2019 10:11 ET (15:11 GMT)

1 Year Genus Chart

1 Year Genus Chart

1 Month Genus Chart

1 Month Genus Chart

Your Recent History

Delayed Upgrade Clock